2 studies found for:    2475911 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Recruiting The Role of Bacteria and Genetic Variations in Cystic Fibrosis
Condition: Lung Diseases
Intervention:
2 Completed A Single Arm 48-Week Follow-on Safety Study to a Core Study Comparing the Efficacy and Tolerability of Tobrineb®/Actitob®/Bramitob® Versus TOBI®
Condition: Cystic Fibrosis
Intervention: Drug: tobramycin

Indicates status has not been verified in more than two years